期刊文献+

适形放疗局部晚期非小细胞肺癌缩小纵隔淋巴结区的对照研究 被引量:7

Treatment of Non-Small Cell Lung Cancer(NSCLC) Using CT in Combination with a PET Examination to Minimize the Clinical Target Volume of the Mediastinum
下载PDF
导出
摘要 目的:CT结合PET肿瘤显像,缩小局部晚期非小细胞肺癌放疗的临床靶区,不做淋巴引流区预防性照射,减少食管和肺的放射损伤。方法:76例局部晚期非小细胞肺癌患者,放疗前32人接受了PET检查,对于CT和PET都认为没有淋巴结转移的纵隔区域不作预防性照射;另44例患者给予常规淋巴引流区预防性照射,PET检查组患者的临床靶体积平均缩小了近1/3。两组患者放疗方法相同,加速分割照射,3Gy/次,5次/周,预防剂量42~45Gy/14~15次/3周,治疗剂量60~63Gy/20~21次/4~5周。结果:PET检查组和非PET检查组照射野外淋巴结失控分别为6.3%和4.5%(P=0.831);急性放射性食管炎的发生率分别为15.6%、和45.5%(P=0.006);两组患者的急性放射性肺炎和远期肺纤维化发生率分别为6.3%、9.1%和68.8%、75.0%(P=0.982和P=0.547)。结论:缩小临床靶体积后,靶区外淋巴结复发率无增加,而放射性肺和食管损伤减轻,尤其是急性放射性食管炎的发生率下降明显。CT结合PET缩小纵隔临床靶体积优于传统的纵隔预防性照射。 Objective: To decrease radiation injury of the esophagus and lungs by utilizing a CT scan in combination with PET tumor imaging in order to minimize the clinical target area of locally advanced non-small cell lung cancer, without preventive radiation on the lymphatic drainage area. Methods: Of 76 patients with locally advanced non-small cell lung cancer (NSCLC), 32 received a PET examination before radiotherapy. Preventive radiation was not conducted in the mediastinum area without lymphatic metastasis, which was confirmed by CT and PET. For the other 44 patients, preventive radiation was performed in the lymphatic drainage area. PET examinations showed that the clinical target volume of the patients was decreased on average to about one third. The radiation therapy for patients of the two groups was the same, i.e. the dose for accelerate fractionated irradiation was 3 Gy/time and 5 time/week. The preventive dose was 42 to 45 Gy/time, 14 to 15 time/week, with 3-week treatment, and the therapeutic dose was 60 to 63 Gy/time, 20 to 21 time/week, with a period of 4 to 5 weeks. Results: The rate of missed lymph nodes beyond the irradiation field was 6.3% and 4.5% respectively in the group with and without PET examination (P=0.831). The incidence of acute radioactive esophagitis was 15.6% and 45.5% in the two groups respectively (P=0.006). The incidence of acute radiation pneumonia and long-term pulmonary fibrosis in the two groups was 6.3% and 9.1%, and 68.8% and 75.0%, respectively (P=0.982 and P=0.547). Conclusion: The recurrence rate in the lymph nodes beyond the target area was not increased after minimizing the clinical target volume (CTV), whereas radioactive injury to the lungs and esophageal injury was reduced, and especially with a significant decrease in the rate of acute radioactive esophagitis. The method of CT in combination with PET for minimizing the mediastinal CTV is superior to the conventional preventive radiation of the mediastinum.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第11期653-656,共4页 Chinese Journal of Clinical Oncology
关键词 非小细胞肺癌 三维适形放射治疗 计算机X线断层扫描 正电子发射型计算机断层扫描 Non-small cell lung cancer Three dimentional conformal radiation therapy Computerized tomography (CT)Positron emission computerized tomographical scanning (PET)
  • 相关文献

参考文献10

  • 1Wagner H. Image--guided conformal radiation therapy planning and delivery for non-small-cell lung cancer [J]. Cancer Control, 2003, 10(4): 277-288.
  • 2Weng E, Tran L, Rege S, et al. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer [J]. Am J Clin Oncol, 2000, 23(1): 47 -52.
  • 3Willner J, Jost A, Baier K, et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose--volume histogram parameters of the lung in patients with lung cancer treated with 3D conformal radiotherapy [J]. Strahlenther Onkol, 2003, 179(8): 548 -556.
  • 4Ahn SJ, Kahn D, Zhou S, et al. Dosimetric and clinical predictors for radiation-induced esophageal injury[J]. Int J Radiat Oncol Biol Phys, 2005, 61(2): 335-347.
  • 5Bryant AS, Cerfolio RJ, Klemm KM, et al. Maximum standard uptake value of mediastinal lymph nodes on integrated FDGPET--CT predicts pathology in patients with non--small cell lung cancer[J]. Ann Thorac Surg, 2006, 82(2): 417-422.
  • 6Nestle U, Kremp S, Grosu AL. Practical integration of [18F]FDG-PET and PET--CT in the planning of radiotherapy for non--small cell lung cancer (NSCLC): the technical basis, ICRUtarget volumes, problems, perspectives [J]. Radiother Oncol, 2006, 81(2): 209-225.
  • 7Aitken CL, Mahmoud F, McGuinness G, et al. Tumor localization and image registration of F-18 FDG coincidence detection scans with computed tomographic scans[J]. Clin Nucl Med, 2002, 27(4): 275-282.
  • 8Singh AK, Lockett MA, Bradley JD. Predictors of radiation-induced csophageal toxicity in patients with non-small-cell lung cancer treated with three--dimensional conformal radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2003, 55(2): 337-341.
  • 9封巍,祝淑钗,翟福山,邱嵘,李娟,王玉祥.三维适形放疗非小细胞肺癌所致食管损伤相关因素分析[J].中华放射肿瘤学杂志,2005,14(2):94-98. 被引量:17
  • 10Schallenkamp JM, Miller RC, Brinkmann DH, et al. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates[J]. Int J Radiat Oncol Biol Phys, 2007, 67(2): 410-416.

二级参考文献9

  • 1Barton M.Tables of equivalent dose in 2 Gy fractions a simple application of linear quadratic formula.Int J Radiat Oncol Biol Phys,1995,31:371-378.
  • 2Byhardt RW,Scott C,Sause WT,et al.Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung.Int J Radiat Oncol Biol Phys,1998, 42:469-478.
  • 3Saunders M, Dische S,Barrett A,et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial.Lancet,1997,350:161.
  • 4Singh AK, Lockett MA,Bradley JD,et al.Radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.Int J Radiat Oncol Biol Phys,2003,55:337-341.
  • 5Maguire PD,Sibley GS,Zhou SM,et al.Clinical and dosimetric predictors of radiation-induced esophageal toxicity.Int J Radiat Oncol Biol Phys,1999, 45:97-103.
  • 6Werner-Wasik M, Pequignot E,Leeper D.Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of the irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.Int J Radiat Oncol Biol Phys,2000,48:689-696.
  • 7Hirota S, Tsujino K, Endo M,et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy.Int J Radiat Oncol Biol Phys,2001,51:291-295.
  • 8Emami B,Lyman J,Brown A,et al.Tolerance of normal tissue to therapeutic irradiation.Int J Radiat Oncol Biol Phys,1991,21:109-122.
  • 9Hirota S,Tsujino K,Hishikawa Y,et al.Endoscopic findings radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies.Radiother Oncol,2001,58:273-278.

共引文献16

同被引文献47

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部